Common Stock, Shares, Issued of Greenwich LifeSciences, Inc. from Q4 2019 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Greenwich LifeSciences, Inc. quarterly Common Stock, Shares, Issued history and change rate from Q4 2019 to Q3 2025.
  • Greenwich LifeSciences, Inc. Common Stock, Shares, Issued for the quarter ending 30 Sep 2025 was 13.8M shares, a 4.94% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Greenwich LifeSciences, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 13.8M +650K +4.94% 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 13.5M +405K +3.1% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 13.2M +317K +2.47% 31 Mar 2025 10-Q 20 May 2025
Q4 2024 13.2M +305K +2.37% 31 Dec 2024 10-Q 14 Nov 2025
Q3 2024 13.1M +296K +2.31% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 13.1M +220K +1.71% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 12.9M +27.1K +0.21% 31 Mar 2024 10-Q 20 May 2024
Q4 2023 12.8M 0 0% 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 12.8M 0 0% 30 Sep 2023 10-Q 19 Oct 2023
Q2 2023 12.8M +73.4K +0.57% 30 Jun 2023 10-Q 21 Aug 2023
Q1 2023 12.8M -103K -0.8% 31 Mar 2023 10-Q 22 May 2023
Q4 2022 12.8M -300K -2.28% 31 Dec 2022 10-K 15 Apr 2024
Q3 2022 12.8M -145K -1.12% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 12.8M -145K -1.13% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 13M +105K +0.81% 31 Mar 2022 10-Q 20 May 2022
Q4 2021 13.1M +444K +3.5% 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 13M +1.02M +8.55% 30 Sep 2021 10-Q 15 Nov 2021
Q2 2021 12.9M 30 Jun 2021 10-Q 13 Aug 2021
Q1 2021 12.8M 31 Mar 2021 10-Q 20 May 2021
Q4 2020 12.7M +4.25M +50.2% 31 Dec 2020 10-K 21 Mar 2022
Q3 2020 12M 30 Sep 2020 10-Q 16 Nov 2020
Q4 2019 8.46M 31 Dec 2019 10-K 31 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.